<DOC>
	<DOCNO>NCT01829243</DOCNO>
	<brief_summary>This study design investigate whether milnacipran safe effective improve cognitive function fibromyalgia . In addition , study aim investigate whether improvement neurocognitive status due milnacipran correlate improvement pain , investigate whether improvement neurocognitive status due milnacipran correlate improvement fatigue , determine whether treatment improvement neurocognitive status , pain fatigue correlate functional improvement .</brief_summary>
	<brief_title>Milnacipran Neurocognition , Pain Fatigue Fibromyalgia : A 13-week Randomized , Placebo Controlled Cross Over Trial</brief_title>
	<detailed_description>Cognitive dysfunction observe fibromyalgia , especially episodic memory , learning , work memory.There evidence dysregulation attention system low-level sensory process emotional process , increase sensitivity distraction.Milnacipran 's balance norepinephrine ( NE ) serotonin ( 5-HT ) 3:1 , similar amitriptyline , tricyclic demonstrate efficacy fibromyalgia , compare venlafaxine 1:30 , duloxetine 1:10.7 In addition , milnacipran 's effect 5-HT , also effective treat symptom sleep disturbance mood change , associate fibromyalgia , well functional somatic syndrome . It worth note several medication treat fibromyalgia sedating ( e.g pregabalin , opioids , muscle relaxant ) impair neurocognition .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>Age 18 65 year . Specific diagnosis FM participant 's rheumatologist physician , include write confirmation , physician , FM diagnosis . Confirmation FM diagnosis American College Rheumatology Criteria physical tender point examination . Ability give inform consent . If female , nonpregnant/nonlactating . If sexually active female reproductive potential , must use adequate contraception ( i.e. , oral contraceptive , barrier protection , prior tubal ligation ) trial . Bipolar disorder , psychotic disorder . existence concomitant rheumatological disorder , include rheumatoid arthritis , systemic lupus erythematosus , Hashimoto 's disease , Sjogren 's syndrome scleroderma . Substance dependence ( except nicotine dependence ) previous 3 month . Currently suicidal high suicide risk . Serious unstable medical disorder . Any psychotropic drug treatment previous 2 week screen . A positive urine pregnancy test . Screening laboratory value three time limit normal judge clinically significant investigator . History hypersensitivity milnacipran . Seizure disorder , traumatic brain injury , CNS disorder affect cognitive status . Concomitant med : A minimum 30 day stable dose analgesic minimum 4 week washout antidepressant fibromyalgia specific medication ( e.g . pregabalin , neurontin ) supplement ( St John 's wort , SAME ) . Narrow angle glaucoma .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Milnacipran</keyword>
	<keyword>Fibromyalgia</keyword>
	<keyword>Neurocognition</keyword>
</DOC>